SCHEMBL1616607

SCHEMBL1616607

O=[N+]([O-])c1cccc2nc(N[C@@H]3CCc4ccccc43)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
PRKCQ Q04759 2/20 0.45
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GBA1 P04062 1/20 0.42
FADS1 O60427 1/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 2/20 0.38
HDAC6 Q9UBN7 1/20 0.38
KCNN3 Q9UGI6 1/20 0.38
PARP1 P09874 2/20 0.38
PDPK1 O15530 1/20 0.38
AURKA O14965 1/20 0.38
RPS6KB1 P23443 1/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616609 1.00 ALDH1A1 (0.45) ALDH1A1PRKCQKDM4EMEN1KMT2A
SCHEMBL2245619 0.82 GBA1 (0.47) GBA1FADS1DDB1CRBNHDAC6
SCHEMBL1616344 0.80 GBA1 (0.46) GBA1FADS1DDB1CRBNHDAC6
SCHEMBL1615945 0.80 GBA1 (0.48) GBA1FADS1DDB1CRBNHDAC6
SCHEMBL1615946 0.80 GBA1 (0.48) GBA1FADS1DDB1CRBNHDAC6
SCHEMBL1616343 0.80 GBA1 (0.46) GBA1FADS1DDB1CRBNHDAC6
SCHEMBL1616241 0.79 GBA1 (0.50) ALDH1A1KDM4EMEN1KMT2AGBA1
SCHEMBL1616249 0.79 GBA1 (0.50) ALDH1A1KDM4EMEN1KMT2AGBA1
SCHEMBL1615788 0.78 GBA1 (0.44) GBA1FADS1DDB1CRBNHDAC6
SCHEMBL3844986 0.78 PDPK1 (0.47) GBA1FADS1DDB1CRBNHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994324-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-09 US disclosed
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US disclosed
EP-2262773-A1 2-AMINOQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP disclosed
EP-2099763-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2009-09-16 EP disclosed
WO-2009109491-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-10 US disclosed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US disclosed
WO-2008068157-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES HTR5A, HTR2C, HTR2B ALDH1A1 2103/4885PRKCQ 789/4885KDM4E 1083/4885
US-20080146567-A1 QUINOLINES HTR5A, HTR2B, HTR2C ALDH1A1 1619/4885PRKCQ 1972/4885KDM4E 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.